Know you’re going to see tiny red dots and possibly bruising on skin treated by acupuncture. This is normal after your acupuncture treatment. You shouldn’t be upset or alarmed. You may experience these kinds of minor side effects without having any greater problems, and without losing the great benefits of a successful acupuncture treatment.
<img src="http://i.imgur.com/BDwpCl1.jpg" title="Vascular Surgeon" try this out alt=”Vascular Surgeon” width=”250″ align=”left”/>
“The Surfacer System is an exciting new technology that offers my patients a promising option for reliable catheter placement during AV access creation.” Early results of the SAVE study will be presented by Vladimir Matoussevitch, MD on Tuesday April 25th from 2:10 – 2:15 p.m. during his presentation ” From the Alien to HeRo: first European in-man case of combined use of the Surfacer Inside-Out Device and the HeRo Graft (S) ” at the Charing Cross (CX) International Symposium in London, United Kingdom. “I am extremely pleased by the early positive results and steady enrollment progress of the SAVE study,” stated Gabriele Niederauer, Ph.D., CEO and President of Bluegrass Vascular. “Over one third of registry patients have been successfully treated across 6 sites in Europe, bringing us one step closer to preserving access options in patients with compromised central vascular access.” Bluegrass Vascular will be co-presenting with Merit Medical Systems (Merit Medical), a prominent distributor of medical devices and world-wide distributor of the Surfacer System, during a lunch symposium on Wednesday, April 26th from 12:30-1:30pm titled Surfacer: from Inside-Out Concept to European Use. The symposium will be presented by Gurkan Sengolge, MD, Associate Professor, Interventional Nephrologist at the University of Vienna and John Gurley, MD, Interventional Cardiologist at the University of Kentucky Medical Center and founder of Bluegrass Vascular. The Surfacer System will also be on display at Merit Medical’s exhibitor booth, #415. The company secured CE Mark approval of the Surfacer System in 2016 and recently announced its strategic, world-wide distribution relationship with Merit Medical, a company dedicated to developing and commercializing lifesaving devices and methods that address shortcomings in vascular access procedures. About the Surfacer Inside-Out Access Catheter System The Surfacer System is designed to reliably, efficiently and repeatedly gain central venous access by inserting the Surfacer System through the femoral vein and navigating it up through the patient’s venous system with an exit point in the right internal jugular vein, the optimal location for placing a central venous catheter. This proprietary Inside-Out approach allows for the placement and maturation of permanent arteriovenous access options that are useful content associated with improved patient outcomes and reduced cost of care for both hospitals and hemodialysis providers.
For the original version including any supplementary images or video, visit http://finance.yahoo.com/news/first-patients-enrolled-bluegrass-vascular-110000929.html